INTRODUCTION:  Colorectal cancer (CRC) is a serious health problem, and various screening programs to reduce CRC have been introduced worldwide. However, the cost-effectiveness of a program based on once-in-a-lifetime colonoscopy in Poland is unknown. OBJECTIVES:  The main aim of this study was to assess the cost-effectiveness of Polish Colonoscopy Screening Platform (PCSP), the colonoscopy screening program in Poland. METHODS:  A Markov model was constructed to compare the strategy of colonoscopy screening vs. no-screening in 100 000 subjects. The model was based on data collected from the nationwide Polish CRC screening program whenever possible. The incremental cost-effectiveness ratio (ICER) was calculated and compared to willingness-to-pay thresholds. A sensitivity analysis was also performed using the Monte Carlo simulation. RESULTS:  Colonoscopy screening within PCSP resulted in a 18.9 % reduction in CRC incidence and 19.8 % reduction in CRC mortality. The strategy allowed a gain of 2317 life-years saved (1959 after discounting). Cost of colonoscopy screening per participant examined was estimated at $267.70 (95% CI $263.08-$272.32). The ICER was <$6500, which was much lower than the accepted willingness-to-pay thresholds, indicating that the screening was cost-effective. CONCLUSIONS:  Colonoscopy screening within the PCSP is cost-effective and may have a substantial impact on Polish society due to life-years saved. The results have good informative value not only for health policy makers and medical practitioners, but also for health technology assessment.

Cost-effectiveness of colonoscopy in the organized screening program

Hassan C;
In corso di stampa

Abstract

INTRODUCTION:  Colorectal cancer (CRC) is a serious health problem, and various screening programs to reduce CRC have been introduced worldwide. However, the cost-effectiveness of a program based on once-in-a-lifetime colonoscopy in Poland is unknown. OBJECTIVES:  The main aim of this study was to assess the cost-effectiveness of Polish Colonoscopy Screening Platform (PCSP), the colonoscopy screening program in Poland. METHODS:  A Markov model was constructed to compare the strategy of colonoscopy screening vs. no-screening in 100 000 subjects. The model was based on data collected from the nationwide Polish CRC screening program whenever possible. The incremental cost-effectiveness ratio (ICER) was calculated and compared to willingness-to-pay thresholds. A sensitivity analysis was also performed using the Monte Carlo simulation. RESULTS:  Colonoscopy screening within PCSP resulted in a 18.9 % reduction in CRC incidence and 19.8 % reduction in CRC mortality. The strategy allowed a gain of 2317 life-years saved (1959 after discounting). Cost of colonoscopy screening per participant examined was estimated at $267.70 (95% CI $263.08-$272.32). The ICER was <$6500, which was much lower than the accepted willingness-to-pay thresholds, indicating that the screening was cost-effective. CONCLUSIONS:  Colonoscopy screening within the PCSP is cost-effective and may have a substantial impact on Polish society due to life-years saved. The results have good informative value not only for health policy makers and medical practitioners, but also for health technology assessment.
In corso di stampa
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/75310
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact